{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:26:20Z","timestamp":1783941980868,"version":"3.55.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY20889"],"award-info":[{"award-number":["EY20889"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["P30EY003790"],"award-info":[{"award-number":["P30EY003790"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["PR9"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Ocular pain is a common complaint to eye care providers, associated with a variety of ocular conditions, among which dry eye disease (DED) is affecting millions of people worldwide. Despite being highly prevalent, ocular pain is not managed adequately in the clinic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>The aim of this study was to investigate the analgesic potential of neurokinin-1 receptor (NK1R) antagonism in DED.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Dry eye disease was induced in mice, and an NK1R antagonist L-733,060 was topically administered twice daily throughout the study for 14 days. Hyperalgesia and allodynia were assessed using the eye-wiping test and palpebral ratio measurements. Corneas were collected for measuring substance P (SP) levels by enzyme-linked immunosorbent assay (ELISA) and imaging nerves by immunostaining. Trigeminal ganglions (TG) were collected to determine SP levels by ELISA and transient receptor potential cation channel subfamily V member 1 (TRPV1), transient receptor potential cation channel\u00a0subfamily M (melastatin) member 8, c-Fos, and activating transcription factor 3 (ATF3) mRNA levels by real-time polymerase chain reaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Treating DED mice with L-733,060 resulted in a significant reduction in eye wipe behavior, a significant increase in palpebral ratio, and significant decreases in SP levels in both the cornea and TG compared with the vehicle-treated group. In addition, NK1R antagonist treatment significantly suppressed the upregulation of TRPV1, ATF3, and c-Fos and prevented corneal nerve loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Neurokinin-1 receptor antagonism effectively reduced ocular nociception, decreased neuronal activation, and preserved corneal nerves in mice with DED. These findings suggest that blockade of SP signaling pathway is a promising therapeutic strategy for managing DED pain.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pr9.0000000000001232","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:00:44Z","timestamp":1737460844000},"page":"e1232","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Topical neurokinin-1 receptor antagonism ameliorates ocular pain and prevents corneal nerve degeneration in an animal model of dry eye disease"],"prefix":"10.1097","volume":"10","author":[{"given":"Amirreza","family":"Naderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Taketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Kahale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Surico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-6182","authenticated-orcid":false,"given":"Yihe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2]]},"reference":[{"key":"R1-20250121","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/ACI.0000000000000389","article-title":"Neuropathic symptoms of the ocular surface: dryness, pain, and itch","volume":"17","author":"Andersen","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R2-20250121","doi-asserted-by":"crossref","first-page":"102266","DOI":"10.1016\/j.npep.2022.102266","article-title":"Role of ocular surface neurobiology in neuronal-mediated inflammation in dry eye disease","volume":"95","author":"Asiedu","year":"2022","journal-title":"Neuropeptides"},{"key":"R3-20250121","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"suppl 1","key":"R4-20250121","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/ICO.0000000000002116","article-title":"Pain, dryness, and itch sensations in eye surface disorders are defined by a balance between inflammation and sensory nerve injury","volume":"38","author":"Belmonte","year":"2019","journal-title":"Cornea"},{"key":"R5-20250121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.exer.2003.09.023","article-title":"Neural basis of sensation in intact and injured corneas","volume":"78","author":"Belmonte","year":"2004","journal-title":"Exp Eye Res"},{"key":"R6-20250121","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1542-0124(12)70112-X","article-title":"Nerves and sensations from the eye surface","volume":"2","author":"Belmonte","year":"2004","journal-title":"Ocul Surf"},{"key":"R7-20250121","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1167\/iovs.18-24304","article-title":"TRPV1 and TRPM8 channels and nocifensive behavior in a rat model for dry eye","volume":"59","author":"Bereiter","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-20250121","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0014-4886(80)90154-5","article-title":"Sensory denervation of the rabbit cornea affects epithelial properties","volume":"69","author":"Beuerman","year":"1980","journal-title":"Exp Neurol"},{"key":"R9-20250121","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S1542-0124(12)70256-2","article-title":"Neurogenic inflammation: a first line of defense for the ocular surface","volume":"3","author":"Beuerman","year":"2005","journal-title":"Ocul Surf"},{"key":"R10-20250121","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1167\/iovs.14-14553","article-title":"NK1 receptor antagonists as a new treatment for corneal neovascularization","volume":"55","author":"Bignami","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-20250121","doi-asserted-by":"crossref","first-page":"114147","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"R12-20250121","doi-asserted-by":"crossref","first-page":"109057","DOI":"10.1016\/j.exer.2022.109057","article-title":"Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease","volume":"219","author":"Blanco-V\u00e1zquez","year":"2022","journal-title":"Exp Eye Res"},{"key":"R13-20250121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.13.2.9","article-title":"Aprepitant restores corneal sensitivity and reduces pain in DED","volume":"13","author":"Bonelli","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"R14-20250121","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jtos.2023.09.004","article-title":"Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration","volume":"30","author":"Bonelli","year":"2023","journal-title":"Ocul Surf"},{"key":"R15-20250121","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"R16-20250121","doi-asserted-by":"crossref","first-page":"15210","DOI":"10.1038\/s41598-020-72295-x","article-title":"Ocular surface inflammation induces de novo expression of substance P in the trigeminal primary afferents with large cell bodies","volume":"10","author":"Byun","year":"2020","journal-title":"Sci Rep"},{"key":"R17-20250121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","article-title":"Mechanisms of neuropathic pain","volume":"52","author":"Campbell","year":"2006","journal-title":"Neuron"},{"key":"R18-20250121","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/32897","article-title":"Primary afferent tachykinins are required to experience moderate to intense pain","volume":"392","author":"Cao","year":"1998","journal-title":"Nature"},{"key":"R19-20250121","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jpain.2010.05.007","article-title":"Central sensitization in the trigeminal nucleus caudalis produced by a conjugate of substance P and the A subunit of cholera toxin","volume":"11","author":"Caudle","year":"2010","journal-title":"J Pain"},{"key":"R20-20250121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mi.2013.20","article-title":"Chronic dry eye disease is principally mediated by effector memory Th17 cells","volume":"7","author":"Chen","year":"2014","journal-title":"Mucosal Immunol"},{"key":"R21-20250121","doi-asserted-by":"crossref","first-page":"102933","DOI":"10.1016\/j.autrev.2021.102933","article-title":"Autoimmunity in dry eye disease\u2014an updated review of evidence on effector and memory Th17 cells in disease pathogenicity","volume":"20","author":"Chen","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R22-20250121","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nn.3144","article-title":"Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology","volume":"15","author":"Chiu","year":"2012","journal-title":"Nat Neurosci"},{"key":"R23-20250121","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMra1407936","article-title":"Dry eye","volume":"378","author":"Clayton","year":"2018","journal-title":"N Engl J Med"},{"key":"R24-20250121","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1152\/jn.1990.64.2.457","article-title":"Contributions of arachidonic acid derivatives and substance P to the sensitization of cutaneous nociceptors","volume":"64","author":"Cohen","year":"1990","journal-title":"J Neurophysiol"},{"key":"R25-20250121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jtos.2021.08.004","article-title":"Alterations in corneal nerves in different subtypes of dry eye disease: an in vivo confocal microscopy study","volume":"22","author":"Cox","year":"2021","journal-title":"Ocul Surf"},{"key":"R26-20250121","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"R27-20250121","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0009-9236(98)90140-0","article-title":"The substance P receptor antagonist CP-99,994 reduces acute postoperative pain","volume":"64","author":"Dionne","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R28-20250121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-021-02162-7","article-title":"Capsazepine decreases corneal pain syndrome in severe dry eye disease","volume":"18","author":"Fakih","year":"2021","journal-title":"J Neuroinflammation"},{"key":"R29-20250121","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/pharmaceutics14091859","article-title":"Transient receptor potential channels: important players in ocular pain and dry eye disease","volume":"14","author":"Fakih","year":"2022","journal-title":"Pharmaceutics"},{"key":"R30-20250121","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12974-019-1656-4","article-title":"Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem","volume":"16","author":"Fakih","year":"2019","journal-title":"J Neuroinflammation"},{"key":"R31-20250121","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jcrs.2014.08.001","article-title":"Efficacy and safety of pain relief medications after photorefractive keratectomy: review of prospective randomized trials","volume":"40","author":"Faktorovich","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R32-20250121","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresprot.2005.10.003","article-title":"Eye-wiping test: a sensitive animal model for acute trigeminal pain studies","volume":"16","author":"Farazifard","year":"2005","journal-title":"Brain Res Protocol"},{"key":"R33-20250121","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","article-title":"Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older","volume":"182","author":"Farrand","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R34-20250121","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1167\/iovs.14-13984","article-title":"Ocular surface injury induces inflammation in the brain: in vivo and ex vivo evidence of a corneal\u2013trigeminal axis","volume":"55","author":"Ferrari","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-20250121","first-page":"205","article-title":"Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs","volume":"99","author":"Flach","year":"2001","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R36-20250121","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","article-title":"Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review","volume":"25","author":"Gaynes","year":"2002","journal-title":"Drug Saf"},{"key":"R37-20250121","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/biomedicines9101424","article-title":"Corneal nerve abnormalities in painful dry eye disease patients","volume":"9","author":"Guerrero-Moreno","year":"2021","journal-title":"Biomedicines"},{"key":"R38-20250121","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","article-title":"NK1 (substance P) receptor antagonists\u2014why are they not analgesic in humans?","volume":"21","author":"Hill","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"R39-20250121","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/jimmunol.1900818","article-title":"Unraveling the plastic peripheral neuroimmune interactome","volume":"204","author":"Jain","year":"2020","journal-title":"J Immunol"},{"key":"R40-20250121","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/PPA.S235430","article-title":"Analysis of patient preferences in lung cancer - estimating acceptable tradeoffs between treatment benefit and side effects","volume":"14","author":"Janssen","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"R41-20250121","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/WNR.0b013e3283572206","article-title":"Substance P induces M2-type macrophages after spinal cord injury","volume":"23","author":"Jiang","year":"2012","journal-title":"Neuroreport"},{"key":"R42-20250121","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/WNR.0b013e3283650e3d","article-title":"Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury","volume":"24","author":"Jiang","year":"2013","journal-title":"Neuroreport"},{"key":"R43-20250121","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0161-6420(97)30135-3","article-title":"A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions","volume":"104","author":"Kaiser","year":"1997","journal-title":"Ophthalmology"},{"key":"R44-20250121","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-7237-1_15","article-title":"Isolation, purification, and culture of primary murine sensory neurons","volume":"1656","author":"Katzenell","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R45-20250121","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1523\/JNEUROSCI.22-20-09086.2002","article-title":"Spinal neurons that possess the substance P receptor are required for the development of central sensitization","volume":"22","author":"Khasabov","year":"2002","journal-title":"J Neurosci"},{"key":"R46-20250121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(97)00564-7","article-title":"Profile of neuronal excitation following selective activation of the neurokinin-1 receptor in rat deep dorsal horn in vitro","volume":"767","author":"King","year":"1997","journal-title":"Brain Res"},{"key":"R47-20250121","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archophthalmol.2011.200","article-title":"Alterations of tear neuromediators in dry eye disease","volume":"129","author":"Lambiase","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R48-20250121","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat Methods"},{"key":"R49-20250121","doi-asserted-by":"crossref","first-page":"e35656","DOI":"10.1371\/journal.pone.0035656","article-title":"The assessment of post-vasectomy pain in mice using behaviour and the Mouse Grimace Scale","volume":"7","author":"Leach","year":"2012","journal-title":"PLoS One"},{"key":"R50-20250121","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1038\/s41467-019-13536-0","article-title":"TRPV1 activity and substance P release are required for corneal cold nociception","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"R51-20250121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuroscience.2015.09.036","article-title":"Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture","volume":"310","author":"Li","year":"2015","journal-title":"Neuroscience"},{"key":"R52-20250121","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1096\/fj.201903236R","article-title":"Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J"},{"key":"R53-20250121","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.exer.2009.12.010","article-title":"Anatomy of the human corneal innervation","volume":"90","author":"Marfurt","year":"2010","journal-title":"Exp Eye Res"},{"key":"R54-20250121","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","article-title":"Neuropeptide substance P and the immune response","volume":"73","author":"Mashaghi","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"R55-20250121","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","article-title":"DeepLabCut: markerless pose estimation of user-defined body parts with deep learning","volume":"21","author":"Mathis","year":"2018","journal-title":"Nat Neurosci"},{"key":"R56-20250121","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1038\/s41598-020-73945-w","article-title":"Lacrimal gland excision in male and female mice causes ocular pain and anxiety-like behaviors","volume":"10","author":"Mecum","year":"2020","journal-title":"Sci Rep"},{"key":"R57-20250121","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(98)00051-7","article-title":"The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis","volume":"76","author":"Mitsikostas","year":"1998","journal-title":"PAIN"},{"key":"R58-20250121","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jtos.2020.07.004","article-title":"Visualization of microneuromas by using in vivo confocal microscopy: an objective biomarker for the diagnosis of neuropathic corneal pain?","volume":"18","author":"Moein","year":"2020","journal-title":"Ocul Surf"},{"key":"R59-20250121","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1254\/jphs.12218FP","article-title":"Volume transmission of substance P in striatum induced by intraplantar formalin injection attenuates nociceptive responses via activation of the neurokinin 1 receptor","volume":"121","author":"Nakamura","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"R60-20250121","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3959(89)90078-X","article-title":"Substance P and peripheral inflammatory hyperalgesia","volume":"38","author":"Nakamura-Craig","year":"1989","journal-title":"PAIN"},{"key":"R61-20250121","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1542-0124(12)70206-9","article-title":"Neurotrophic mediators and corneal wound healing","volume":"3","author":"Nishida","year":"2005","journal-title":"Ocul Surf"},{"key":"R62-20250121","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1523\/JNEUROSCI.15-11-07633.1995","article-title":"Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons","volume":"15","author":"Noguchi","year":"1995","journal-title":"J Neurosci"},{"key":"R63-20250121","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1177\/0022034510377094","article-title":"Substance P sensitizes P2X3 in nociceptive trigeminal neurons","volume":"89","author":"Park","year":"2010","journal-title":"J Dent Res"},{"key":"R64-20250121","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1167\/iovs.06-0728","article-title":"New tools for the evaluation of toxic ocular surface changes in the rat","volume":"48","author":"Pauly","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R65-20250121","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/eujp.2000.0222","article-title":"The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat","volume":"5","author":"Pawlak","year":"2001","journal-title":"Eur J Pain"},{"key":"R66-20250121","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pain.2009.06.037","article-title":"Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision","volume":"145","author":"Sahbaie","year":"2009","journal-title":"PAIN"},{"key":"R67-20250121","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/physrev.00025.2008","article-title":"Models and mechanisms of hyperalgesia and allodynia","volume":"89","author":"Sandk\u00fchler","year":"2009","journal-title":"Physiol Rev"},{"key":"R68-20250121","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2017.05.009","article-title":"Determinants of ocular pain severity in patients with dry eye disease","volume":"179","author":"Satitpitakul","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R69-20250121","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/ICO.0000000000002580","article-title":"Ocular discomfort and quality of life among patients in the dry eye assessment and management study","volume":"40","author":"Sayegh","year":"2021","journal-title":"Cornea"},{"key":"R70-20250121","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archopht.1954.00920050048005","article-title":"Mitotic and wound-healing activities of the corneal epithelium; effect of sensory denervation","volume":"52","author":"Sigelman","year":"1954","journal-title":"AMA Arch Ophthalmol"},{"key":"R71-20250121","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1167\/iovs.18-26318","article-title":"Changes in murine subbasal corneal nerves after scopolamine-induced dry eye stress exposure","volume":"60","author":"Simsek","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R72-20250121","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtos.2022.06.007","article-title":"Modulating the tachykinin: role of substance P and neurokinin receptor expression in ocular surface disorders","volume":"25","author":"Singh","year":"2022","journal-title":"Ocul Surf"},{"key":"R73-20250121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the epidemiology subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Smith","year":"2007","journal-title":"Ocul Surf"},{"key":"R74-20250121","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pain.2009.04.013","article-title":"Differential regulation of TRP channels in a rat model of neuropathic pain","volume":"144","author":"Staaf","year":"2009","journal-title":"PAIN"},{"key":"R75-20250121","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"R76-20250121","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/ICU.0000000000000753","article-title":"Opioids and ophthalmology: review of the current literature","volume":"32","author":"Starr","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"R77-20250121","doi-asserted-by":"crossref","first-page":"101964","DOI":"10.1016\/j.ajoc.2023.101964","article-title":"Topical fosaprepitant for the treatment of ocular pain and inflammation","volume":"32","author":"Suanno","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R78-20250121","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.1601751","article-title":"Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis","volume":"199","author":"Suvas","year":"2017","journal-title":"J Immunol"},{"key":"R79-20250121","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.ajpath.2020.05.011","article-title":"Restoration of regulatory T-cell function in dry eye disease by antagonizing substance P\/Neurokinin-1 receptor","volume":"190","author":"Taketani","year":"2020","journal-title":"Am J Pathol"},{"key":"R80-20250121","first-page":"1286","article-title":"Neurokinin-1 receptor antagonism ameliorates ocular pain and immune responses in dry eye disease","volume":"62","author":"Taketani","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R81-20250121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/mcne.1999.0814","article-title":"Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury","volume":"15","author":"Tsujino","year":"2000","journal-title":"Mol Cel Neurosci"},{"key":"R82-20250121","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/iovs.62.3.26","article-title":"Modulating ocular surface pain through neurokinin-1 receptor blockade","volume":"62","author":"Lasagni Vitar","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R83-20250121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/iovs.62.13.21","article-title":"A hypothalamic-controlled neural reflex promotes corneal inflammation","volume":"62","author":"Lasagni Vitar","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R84-20250121","first-page":"CD009781","article-title":"Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions","volume":"5","author":"Wakai","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R85-20250121","first-page":"1765","article-title":"Neuronal plasticity: increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science (1979)"},{"key":"R86-20250121","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biocel.2017.05.030","article-title":"Substance P enhances endogenous neurogenesis to improve functional recovery after spinal cord injury","volume":"89","author":"Yang","year":"2017","journal-title":"Int J Biochem Cel Biol"},{"key":"R87-20250121","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"R88-20250121","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajpath.2019.09.020","article-title":"Neurokinin-1 receptor antagonism ameliorates dry eye disease by inhibiting antigen-presenting cell maturation and T helper 17 cell activation","volume":"190","author":"Yu","year":"2020","journal-title":"Am J Pathol"},{"key":"R89-20250121","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0306-4522(94)90036-1","article-title":"Effects of descending inhibitory systems on the c-Fos expression in the rat spinal cord during formalin-induced noxious stimulation","volume":"58","author":"Zhang","year":"1994","journal-title":"Neuroscience"}],"container-title":["PAIN Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PR9.0000000000001232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:01:07Z","timestamp":1737460867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PR9.0000000000001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pr9.0000000000001232","relation":{},"ISSN":["2471-2531"],"issn-type":[{"value":"2471-2531","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"2023-10-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}